Viewing Study NCT01884961


Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-05-19 @ 9:09 AM
Study NCT ID: NCT01884961
Status: COMPLETED
Last Update Posted: 2025-01-13
First Post: 2013-06-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Renal Cell Cancer View
None Malignant Melanoma, Metastatic View
Keywords: